Mucus Relief Extended Release Tablet
Product Images NDC 70000-0479

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Mucus Relief Extended Release (NDC 70000-0479). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 110, Llc. Dba Leader 70000, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Guaifenesin 1200 mg (Mucus Relief 1200 mg Extended Release Caplets 1)

Guaifenesin 1200 mg (Mucus Relief 1200 mg Extended Release Caplets 1)
This is a drug information on an extended-release Mucus Relief medication containing Guaifenesin as the active ingredient. It helps in loosening phlegm and thinning bronchial secretions to make coughs more productive. The medication is only suitable for adults and children aged 12 years and above. It is not recommended for children below 12 years of age. Pregnant and breastfeeding mothers should see a health professional before use. If cough symptoms persist beyond seven days, it is advisable to consult a doctor. Overdose effects can be dangerous, and medical help should be sought immediately. The inactive ingredients are carvomer colidalsiicon dioxide, FORC blue #1 aluminum ke, REEVE @l H @lelglel-ulely], lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. The product has a tamper-evident, and the outer carton contains warnings and product information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.